Sandra E. Ghayad

1.9k total citations
29 papers, 988 citations indexed

About

Sandra E. Ghayad is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sandra E. Ghayad has authored 29 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Sandra E. Ghayad's work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (6 papers) and Estrogen and related hormone effects (5 papers). Sandra E. Ghayad is often cited by papers focused on MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (6 papers) and Estrogen and related hormone effects (5 papers). Sandra E. Ghayad collaborates with scholars based in France, Lebanon and United States. Sandra E. Ghayad's co-authors include Pascale A. Cohen, Julie A. Vendrell, Charles Dumontet, Ivan Bièche, Raya Saab, Sabrina Ben Larbi, Isabelle Treilleux, Rosette Lidereau, Nadir Mechti and Nader Hussein and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Oncogene.

In The Last Decade

Sandra E. Ghayad

29 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra E. Ghayad France	18	683	319	294	165	111	29	988
Michelle Van Scoyk United States	15	896 1.3×	245 0.8×	226 0.8×	141 0.9×	64 0.6×	27	1.2k
Yong Zou China	20	810 1.2×	390 1.2×	218 0.7×	284 1.7×	97 0.9×	48	1.2k
Subbulakshmi Virudachalam United States	18	705 1.0×	274 0.9×	381 1.3×	160 1.0×	109 1.0×	21	1.2k
Raisa I. Krutilina United States	17	724 1.1×	324 1.0×	240 0.8×	84 0.5×	80 0.7×	43	1.0k
Hefen Sun China	20	585 0.9×	341 1.1×	329 1.1×	157 1.0×	45 0.4×	44	995
Jamunarani Veeraraghavan United States	17	393 0.6×	258 0.8×	346 1.2×	192 1.2×	108 1.0×	36	880
Limei Xu China	14	805 1.2×	303 0.9×	148 0.5×	253 1.5×	72 0.6×	24	1.1k
Alejandro J. Urtreger Argentina	19	679 1.0×	214 0.7×	306 1.0×	68 0.4×	123 1.1×	41	1.0k
Elżbieta Płuciennik Poland	19	604 0.9×	261 0.8×	255 0.9×	111 0.7×	330 3.0×	69	1.1k
Farzaneh Pirnia United States	12	805 1.2×	248 0.8×	507 1.7×	177 1.1×	74 0.7×	14	1.2k

Countries citing papers authored by Sandra E. Ghayad

Since Specialization

Citations

This map shows the geographic impact of Sandra E. Ghayad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra E. Ghayad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra E. Ghayad more than expected).

Fields of papers citing papers by Sandra E. Ghayad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra E. Ghayad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra E. Ghayad. The network helps show where Sandra E. Ghayad may publish in the future.

Co-authorship network of co-authors of Sandra E. Ghayad

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra E. Ghayad. A scholar is included among the top collaborators of Sandra E. Ghayad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra E. Ghayad. Sandra E. Ghayad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghayad, Sandra E., Bassam Badran, René Grée, et al.. (2023). Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents. International Journal of Molecular Sciences. 24(12). 10399–10399. 11 indexed citations

Albaret, Marie Alexandra, Julien Textoris, Bastien Dalzon, et al.. (2023). HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease. Translational Psychiatry. 13(1). 86–86. 14 indexed citations

Ghayad, Sandra E., et al.. (2020). Signaling pathways in Rhabdomyosarcoma invasion and metastasis. Cancer and Metastasis Reviews. 39(1). 287–301. 47 indexed citations

Farhat, Diana, Sophie Léon, Sandra E. Ghayad, et al.. (2020). Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation. British Journal of Cancer. 122(6). 885–894. 24 indexed citations

Kobeissy, Firas, Yehia Mechref, Jingfu Zhao, et al.. (2020). Effects of the Oncoprotein PAX3-FOXO1 on Modulation of Exosomes Function and Protein Content: Implications on Oxidative Stress Protection and Enhanced Plasticity. Frontiers in Oncology. 10. 1784–1784. 8 indexed citations

Farhat, Diana, Sandra E. Ghayad, Philippe Icard, et al.. (2020). Lipoic acid-induced oxidative stress abrogates IGF-1R maturation by inhibiting the CREB/furin axis in breast cancer cell lines. Oncogene. 39(17). 3604–3610. 17 indexed citations

Wierinckx, Anne, Balázs Győrffy, Aurélie Escande, et al.. (2020). Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay. Frontiers in Oncology. 10. 712–712. 17 indexed citations

El-Hachem, Nehmé, Sandra E. Ghayad, Nada Borghol, et al.. (2019). gem-Difluorobisarylic derivatives: design, synthesis and anti-inflammatory effect. BMC Chemistry. 13(1). 124–124. 2 indexed citations

Ghayad, Sandra E., et al.. (2019). The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486. Scientific Reports. 9(1). 14242–14242. 38 indexed citations

10.

Ghayad, Sandra E., et al.. (2016). Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts. Scientific Reports. 6(1). 37088–37088. 49 indexed citations

11.

Nawaz, Zafar, Sandra E. Ghayad, Mark N. Jabbour, et al.. (2015). p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells. Molecular and Cellular Biology. 36(3). 438–451. 19 indexed citations

12.

Ghayad, Sandra E., et al.. (2014). CDK2 Transcriptional Repression Is an Essential Effector in p53-Dependent Cellular Senescence—Implications for Therapeutic Intervention. Molecular Cancer Research. 13(1). 29–40. 26 indexed citations

13.

Vilquin, Paul, Marie Villedieu, Sabrina Ben Larbi, et al.. (2013). Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK‐2206 with an aromatase inhibitor. International Journal of Cancer. 133(7). 1589–1602. 40 indexed citations

14.

Vendrell, Julie A., Aurélie Thollet, Nhan Trung Nguyen, et al.. (2012). ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion. Cancer Research. 72(14). 3593–3606. 95 indexed citations

15.

Vendrell, Julie A., Léa Payen, Sandra E. Ghayad, et al.. (2010). ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells. Molecular Cancer. 9(1). 291–291. 40 indexed citations

16.

Ghayad, Sandra E. & Pascale A. Cohen. (2009). Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients. Recent Patents on Anti-Cancer Drug Discovery. 5(1). 29–57. 143 indexed citations

17.

Ghayad, Sandra E., Julie A. Vendrell, Sabrina Ben Larbi, et al.. (2009). Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways. International Journal of Cancer. 126(2). 545–562. 99 indexed citations

18.

Ghayad, Sandra E., Julie A. Vendrell, Ivan Bièche, et al.. (2008). Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. Journal of Molecular Endocrinology. 42(2). 87–103. 55 indexed citations

19.

Cohen, Pascale A., Ivan Bièche, Julie A. Vendrell, et al.. (2008). mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene expression levels. European Journal of Cancer Supplements. 6(9). 83–83. 1 indexed citations

20.

Ghayad, Sandra E., Ivan Bièche, Julie A. Vendrell, et al.. (2008). mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene‐expression levels. Cancer Science. 99(10). 1992–2003. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact